Does hormone replacement therapy have a future?
نویسندگان
چکیده
منابع مشابه
Hormone replacement therapy menopause with a better future--a survey of views on hormone replacement therapy (HRT).
OBJECTIVE To assess the views and prescribing practices of doctors regarding hormone replacement therapy (HRT). METHODS In April 1999, 103 doctors from a teaching hospital participated in a survey. Using a self-administered questionnaire, subjects were contacted at the departments of Internal Medicine, Family Medicine, Obstetrics and Gynaecology, and Orthopaedics. RESULTS Seventy-two percen...
متن کاملCell therapy for autoimmune diseases: does it have a future?
Almost all current therapeutic concepts in autoimmune diseases are based on the systemic suppression of immune functions and are not curative. The recent introduction of biologicals such as tumour necrosis factor blocking antibodies or receptors has added greater specificity to efficient management of disease by targeted suppression of rheumatic inflammation. It is evident, however, that only t...
متن کاملDoes Proton Therapy Have a Future in CNS Tumors?
OPINION STATEMENT Proton therapy is characterized by certain physical properties leading to a reduction in integral dose. As proton therapy becomes more widely available, the ongoing discussion on the real indications for proton therapy becomes more important. In the present article, data on proton therapy for tumors of the central nervous system (CNS) is summarized and discussed in view of mod...
متن کاملHeight in Turner syndrome: does growth hormone therapy have impact?
Sir Short stature is a cardinal feature of Turner syndrome. We examined height outcome and its relation to growth hormone therapy in Irish girls with Turner syndrome. In those with Turner syndrome (TS), the adult stature is an average 20 cm shorter than the general population 1 . By 15 years of age, the average height of an untreated girl with TS is equivalent to that of only a 9.5-year-old gir...
متن کاملHormone replacement therapy.
HRT is indicated for the treatment of moderate ▪ to severe vasomotor and urogenital symptoms associated with menopause. HRT is not recommended for primary prevention of ▪ disease because of increased risk of other adverse events. The use of HRT increases the risk of stroke, venous ▪ thromboembolism (VTE) and gall bladder disease and combined oestrogen progestogen therapy is also associated with...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Women's Health
سال: 2005
ISSN: 1745-5057,1745-5065
DOI: 10.2217/17455057.1.1.5